Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone)

BETHESDA, Maryland and ABINGDON, Oxfordshire, July 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the...
July 22, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results and Corporate Update Teleconference and Webcast on August 5

BETHESDA, Md., July 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2014...
July 07, 2014 16:48 ET | Source: Sucampo Pharmaceuticals Inc

Swissmedic Approves AMITIZA(R) (Lubiprostone) for the Treatment of Opioid-Induced Constipation

BETHESDA, Md. and ZUG, Switzerland, July 7, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Swissmedic, the...
June 17, 2014 20:06 ET | Source: Sucampo Pharmaceuticals Inc

AMITIZA(R) (Lubiprostone) Receives NICE Recommendation

BETHESDA, Md., June 17, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the United Kingdom's (U.K.) National...
June 12, 2014 14:41 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Issues Statement Regarding Anesthetic and Analgesic Drug Products Advisory Committee Meeting's Vote

BETHESDA, Md., June 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today issued the following statement regarding the...
May 29, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Webcast of Its Presentation at 2014 Jefferies Global Healthcare Conference

BETHESDA, Md., May 29, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
May 13, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Webcast of Its Presentation at the 2014 UBS Global Healthcare Conference

BETHESDA, Md., May 13, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
May 07, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals, Inc., Reports First Quarter 2014 Financial and Operating Results

Strong Financial Performance Driven by Year over Year Income and Revenue Growth Company to host conference call today at 5:00 pm Eastern BETHESDA, Md., May 7, 2014 (GLOBE NEWSWIRE) -- Sucampo...
May 06, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal

BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...
May 01, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences

BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...